3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 2
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
14
Gastrointestinal
3
Thoracic
2
Other solid neoplasm
2
Sarcoma
1
Conditions
Stomach Neoplasms
3
Ovarian Neoplasms
3
Peritoneal Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Pleural Effusion
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Liposarcoma
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Ascites
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
7
Carboplatin
5
Cisplatin
4
Drug Therapy
3
Taxes
2
Specimen Handling
2
SS1(dsFv)PE38
2
Polymerase Chain Reaction
2
Paclitaxel
2
Oxaliplatin
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gene Expression Profiling
2
Fluorouracil
2
Doxorubicin
2
Cyclophosphamide
2
130-nm albumin-bound paclitaxel
2
tremelimumab
1
tocilizumab
1
tinostamustine
1
sodium thiosulfate
1
selinexor
1
rucaparib
1
olaparib
1
motexafin lutetium
1
liposomal doxorubicin
1
fludarabine
1
eribulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled
NCT02349958
2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2
Unknown
200 enrolled